← Back to Clinical Trials
Recruiting NCT06802471

Efficacy and Central Mechanisms of Electroacupuncture for Medication Overuse Headache

Trial Parameters

Condition Medication Overuse Headache
Sponsor Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Study Type INTERVENTIONAL
Phase N/A
Enrollment 160
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2025-02-01
Completion 2026-12
Interventions
electroacupunctureSham electroacupuncture

Brief Summary

Acupuncture is commonly used for the prevention of migraine and tension-type headaches, and has been found to be effective in reducing both the frequency and severity of these conditions. However, studies on acupuncture for medication overuse headache (MOH) are limited, and current research has not been able to determine whether its efficacy is due to the actual therapeutic effects of acupuncture or psychological benefits. To address this issue, the investigators have designed a clinical trial to evaluate the efficacy of acupuncture for MOH. In addition, the investigators will explore the regulatory effects of electroacupuncture on central mechanisms in MOH and conduct multi-omics analysis.

Eligibility Criteria

Inclusion Criteria for Patients with MOH: * Meet the diagnostic criteria of MOH in ICHD-3; * A history of migraine (according to ICHD-3 criteria)/tension headache (TTH) (according to ICHD-3 criteria) for ≥12 months before screening; * Patients entered data from the electronic headache diary for at least 24 of the 28 days of the screening period (evidence of good adherence to the electronic headache diary); * Prospectively collected data from the electronic headache diary during the screening period met the following criteria: 15 or more headache days per month; Regular overdose of acute or symptomatic headache medications meets the diagnostic criteria for MOH; * Headache diagnosed before the age of 50 years; * Patients had failed MOH withdrawal treatment (with medical documentation or specific physician confirmation of each treatment) on ≥1 occasions in the previous 3 years; Withdrawal treatment failure is defined as no significant reduction in headache frequency, duration and/or sever

Related Trials